Pliant Therapeutics, Inc.
Cash Flow Statement
| Line Item | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sep 2020 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-29.5M | $-28.1M | $-24.5M | $-27.0M | $-22.8M | $-22.9M | $-19.0M | $-16.5M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | $400.0K | $455.0K | $376.0K | $400.0K | $400.0K | $359.0K | $398.0K | $300.0K |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $3.4M | $3.5M | $2.8M | $2.8M | $2.3M | $2.6M | $1.5M | $1.2M |
| Net Cash from Operating Activities | $-24.4M | $-20.5M | $-19.9M | $-22.5M | $-19.4M | $-13.7M | $-16.5M | $-15.8M |
| Investing Activities | ||||||||
| Capital Expenditures | $254.0K | $644.0K | $592.0K | $480.0K | $639.0K | $242.0K | $587.0K | $323.0K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $6.5M | $1.5M | $25.8M | $32.1M | $3.6M | $12.2M | $11.9M | $-105.1M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $10.4M | $-153.0K | $516.0K | $449.0K | $192.0K | $1.4M | $237.0K | $-2.4M |
| Net Change in Cash | $-7.5M | $-19.1M | $6.4M | $10.0M | $-15.6M | $-63.0K | $-4.3M | $-123.2M |
| Free Cash Flow | $-24.7M | $-21.1M | $-20.5M | $-23.0M | $-20.0M | $-13.9M | $-17.1M | $-16.1M |